Greater Washington Oncology Associates

Greater Washington Oncology Associates was paid $740K by Medicaid between Jan 2018 and Apr 2021, across 26 billing codes. Its largest line is 99232, hospital visit by a doctor, follow-up day — 17% of everything it billed.

33Billing provider infoGREATER WASHINGTON ONCOLOGY ASSOCIATES
SILVER SPRING, MD 20901

33aNPI1740396761assigned 08/22/2006

33bProvider typeHematology & Oncology Physician

28Total paid$740K

24GClaims50,523

24DCodes billed26

24AFirst – last monthJan 2018 – Apr 2021

Compared with peers

Next to other Hematology & Oncology Physician providers in Maryland

Rank by total paid#7 of 30

Median peer was paid$116K

This provider vs. median6.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	14,497	$204K
2019	15,116	$195K
2020	18,118	$287K
2021	2,792	$54K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99232	Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity	17%	4,128	1,417	$125K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	16%	2,695	2,126	$115K
J7050	Infusion, normal saline solution, 250 cc	13%	7,314	2,876	$94K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	11%	4,806	2,970	$78K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	9.6%	2,662	896	$71K
99231	Subsequent hospital care, per day, straightforward or low complexity	8.5%	3,881	1,604	$63K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	7.8%	1,547	657	$58K
96375	Therapeutic injection; each additional sequential IV push	7.4%	5,167	1,956	$54K
J1756	Injection, iron sucrose, 1 mg	2.1%	1,239	514	$16K
96417		1.5%	480	187	$11K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	1.5%	111	79	$11K
36415	Collection of venous blood by venipuncture	1.4%	4,838	2,260	$10K

14 more codes

99214	Doctor's office visit, returning patient (more involved)	1.2%	128	$9K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	1.0%	163	$8K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.0%	1,817	$8K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	269	$2K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	223	$2K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	107	$2K
J2780	Injection, ranitidine hydrochloride, 25 mg	<1%	1,246	$1K
99223	Prolong inpt eval add15 m	<1%	41	$1K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	1,953	$808.85
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	2,477	$780.97
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	2,247	$303.68
J3490	Unclassified drugs	<1%	171	$159.89
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	796	$22.70
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTREHAN, RAM (MANAGING PARTNER)